Skip to main content
Clinical Trials/CTRI/2025/03/081801
CTRI/2025/03/081801
Not yet recruiting
Phase 2

Role of Incentive Spirometry after Burr Hole Evacuation of Chronic Subdural Hematomas: A Randomized Controlled Trial

RAHUL SAIKIA1 site in 1 country444 target enrollmentStarted: March 20, 2025Last updated:

Overview

Phase
Phase 2
Status
Not yet recruiting
Sponsor
RAHUL SAIKIA
Enrollment
444
Locations
1
Primary Endpoint
The primary outcome is the recurrence rate following burr-hole evacuation.

Overview

Brief Summary

Chronic subdural hematomas are a common clinical condition encountered in day-to-day neurosurgical practice. Management of chronic subdural hematomas may be either surgical or conservative. Burr hole drainage is currently the most common surgery used worldwide for the treatment of chronic subdural hematomas. However, recurrence after surgical evacuation is a common problem and has been found to occur in the range of (5-30)%. A number of factors are associated with post-operative recurrence following surgical evacuation such as male gender, elderly age group, bilateral hematoma etc. Several adjuvant therapies with surgery are investigated for preventing recurrence which includes corticosteroids, atorvastatin and middle meningeal artery embolization. 3 ball incentive spirometry has been used in our institution following subdural hematoma evacuation to prevent recurrence. The main mechanism driving this idea is to increase the intracranial pressure and promote brain expansion which ultimately results in drainage of blood products.

Hence, this study is conducted to analyze the effect of incentive spirometry in preventing recurrence following burr-hole evacuation of chronic subdural hematoma.

Study Design

Study Type
Interventional
Allocation
Randomized
Masking
None

Eligibility Criteria

Ages
18.00 Year(s) to 90.00 Year(s) (—)
Sex
All

Inclusion Criteria

  • 1.Patients with CT scans suggestive of chronic subdural hematoma undergoing burr hole evacuation.
  • 2.Patients with GCS more than 13.

Exclusion Criteria

  • 1.Patients with acute subdural hematoma.
  • 2.Patients with chronic subdural hematoma and GCS less than equal to
  • 3.Patients with contraindications for spirometry (e.g. recent MI, unstable angina, bullous emphysema) 4.Patients not willing to participate in the study.

Outcomes

Primary Outcomes

The primary outcome is the recurrence rate following burr-hole evacuation.

Time Frame: The follow-up CT brain will be at 1 and 3 months to detect any recurrence

Secondary Outcomes

  • The secondary outcome will be the resolution of chronic SDH following burr hole evacuation(The follow-up CT brain will be done at 1 and 3 months to check for resolution)

Investigators

Sponsor
RAHUL SAIKIA
Sponsor Class
Other [self]
Responsible Party
Principal Investigator
Principal Investigator

RAHUL SAIKIA

Institute of Neurosciences, Kolkata

Study Sites (1)

Loading locations...

Similar Trials